Biocryst Pharmaceuticals Inc
BCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000882796
No open-market purchases or sales by Biocryst Pharmaceuticals Inc insiders were filed in the last 90 days; 319 institutions reported holding it in 13F filings for Q2 2026, worth $2.61B in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Biocryst Pharmaceuticals Inc as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 236
- −5 vs. Q1 2023
- Shares held
- 174.1M
- +3.94M (+2.3%) vs. Q1 2023
- Total value
- $1.23B
- −$196.6M (−13.8%) vs. Q1 2023
- New holders
- 26
- 99 more added
- Sold out
- 31
- 57 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 319 | $2.61B |
| Q1 2026 | 303 | $2.37B |
| Q4 2025 | 273 | $1.66B |
| Q3 2025 | 286 | $1.47B |
| Q2 2025 | 294 | $1.77B |
| Q1 2025 | 274 | $1.32B |
| Q4 2024 | 258 | $1.26B |
| Q3 2024 | 257 | $1.32B |
| Q2 2024 | 242 | $1.08B |
| Q1 2024 | 238 | $915.0M |
| Q4 2023 | 236 | $1.06B |
| Q3 2023 | 233 | $1.24B |
| Q2 2023 | 236 | $1.23B |
| Q1 2023 | 242 | $1.42B |
| Q4 2022 | 230 | $1.80B |
| Q3 2022 | 234 | $1.87B |
| Q2 2022 | 221 | $1.61B |
| Q1 2022 | 233 | $2.07B |
| Q4 2021 | 206 | $1.63B |
| Q3 2021 | 197 | $1.48B |
| Q2 2021 | 195 | $1.65B |
| Q1 2021 | 191 | $1.06B |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Biocryst Pharmaceuticals Inc; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 1,059,561 | $7.46M | 0.01% | +154,491+17.1% | Added |
| Jacobs Levy Equity Management, Inc | 1,155,723 | $8.14M | 0.05% | −878,620−43.2% | Reduced |
| ExodusPoint Capital Management, LP | 1,212,547 | $8.54M | 0.10% | −9,134−0.7% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 1,322,000 | $9.31M | 0.20% | −1,443,000−52.2% | Reduced |
| Two Sigma Investments, LP | 1,331,488 | $9.37M | 0.03% | −8,830−0.7% | Reduced |
| Bank of America Corp | 1,358,158 | $9.56M | 0.00% | −2,256,175−62.4% | Reduced |
| Charles Schwab Investment Management Inc | 1,441,405 | $10.1M | 0.00% | +18,285+1.3% | Added |
| Goldman Sachs Group Inc | 1,478,789 | $10.4M | 0.00% | +352,083+31.2% | Added |
| Alkeon Capital Management LLC | 1,672,313 | $11.8M | 0.07% | +403,461+31.8% | Added |
| Northern Trust Corp | 1,837,521 | $12.9M | 0.00% | +74,422+4.2% | Added |
| Stifel Financial Corp | 1,844,554 | $13.0M | 0.02% | +4800.0% | Added |
| Rice Hall James & Associates, LLC | 1,872,964 | $13.2M | 0.75% | +1,872,964 | New |
| Eventide Asset Management, LLC | 1,970,000 | $13.9M | 0.23% | +867,111+78.6% | Added |
| Segall Bryant & Hamill, LLC | 2,037,688 | $14.3M | 0.15% | +199,834+10.9% | Added |
| Two Sigma Advisers, LP | 2,137,612 | $15.0M | 0.04% | −65,100−3.0% | Reduced |
| Eversept Partners, LP | 2,372,113 | $16.7M | 1.76% | −2,148,611−47.5% | Reduced |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 2,410,190 | $17.0M | 0.05% | −477,549−16.5% | Reduced |
| Tang Capital Management LLC | 2,450,000 | $17.2M | 2.54% | +850,000+53.1% | Added |
| Rock Springs Capital Management LP | 2,497,193 | $17.6M | 0.42% | +163,108+7.0% | Added |
| Prosight Management, LP | 2,500,000 | $17.6M | 5.15% | +1,425,407+132.6% | Added |
| GW&K Investment Management, LLC | 2,598,242 | $18.3M | 0.17% | −5,689−0.2% | Reduced |
| Braidwell LP | 2,791,880 | $19.7M | 0.64% | +846,746+43.5% | Added |
| Kynam Capital Management, LP | 2,848,197 | $20.1M | 3.07% | +1,848,197+184.8% | Added |
| FMR LLC | 2,949,798 | $20.8M | 0.00% | −217,712−6.9% | Reduced |
| Geode Capital Management, LLC | 3,832,555 | $27.0M | 0.00% | +178,999+4.9% | Added |
| RP Management, LLC | 3,846,154 | $27.1M | 27.82% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 4,004,700 | $28.2M | 0.10% | +3,951,200+7,385.4% | Added |
| Fisher Asset Management, LLC | 4,324,553 | $30.4M | 0.02% | +31,157+0.7% | Added |
| Pictet Asset Management SA | 5,286,536 | $37.2M | 0.04% | −331,836−5.9% | Reduced |
| Millennium Management LLC | 5,302,020 | $37.3M | 0.04% | +864,691+19.5% | Added |
| Assenagon Asset Management S.A. | 5,332,914 | $37.5M | 0.15% | +365,077+7.3% | Added |
| Avoro Capital Advisors LLC | 12,055,000 | $84.9M | 1.15% | +1,635,000+15.7% | Added |
| State Street Corp | 12,263,969 | $86.3M | 0.00% | +874,346+7.7% | Added |
| Baker Bros. Advisors LP | 12,710,818 | $89.5M | 0.52% | 00.0% | Unchanged |
| Vanguard Group Inc | 15,090,049 | $106.2M | 0.00% | +263,936+1.8% | Added |
| BlackRock Inc. | 15,495,703 | $109.1M | 0.00% | +670,905+4.5% | Added |
| Artisan Partners Limited Partnership | 0 | $0 | 0.00% | −2,837,924−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −2,162,411−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −701,580−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | – | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −385,208−100.0% | Sold out |
| Lombard Odier Asset Management (Switzerland) SA | 0 | $0 | 0.00% | −317,901−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −126,699−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −100,976−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −67,909−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −63,313−100.0% | Sold out |
| International Biotechnology Trust PLC | 0 | $0 | 0.00% | −57,000−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −25,030−100.0% | Sold out |
| North Star Investment Management Corp. | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Landscape Capital Management, L.L.C. | 0 | $0 | 0.00% | −18,705−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −16,500−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −16,300−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −15,825−100.0% | Sold out |
| Brown Brothers Harriman & Co | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| We Are One Seven, LLC | 0 | $0 | 0.00% | −10,006−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −4,740−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −3,567−100.0% | Sold out |
| Baillie Gifford & Co | 0 | $0 | 0.00% | −1,687−100.0% | Sold out |
| Ameritas Advisory Services, LLC | 0 | $0 | 0.00% | −1,244−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −1,126−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −233−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −211−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −93−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| Schubert & Co | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Steward Financial Group LLC | 0 | $0 | 0.00% | −57−100.0% | Sold out |
| ETF Managers Group, LLC | – | – | – | – | Not filed |